Global Head, Scientific Communication

Company Overview

Scholar Rock is a biopharmaceutical company that discovers, develops, and delivers life‑changing therapies for people with serious diseases that have high unmet need. As a global leader in the biology of the transforming growth factor beta (TGFβ) superfamily of cell proteins and named for the visual resemblance of a scholar rock to protein structures, the clinical‑stage company is focused on advancing innovative treatments where protein growth factors are fundamental.

Over the past decade, the company has created a pipeline with the potential to advance the standard of care for neuromuscular disease, cardiometabolic disorders, cancer, and other conditions where growth factor‑targeted drugs can play a transformational role.

Scholar Rock is the only company to show clinical proof of concept for a muscle‑targeted treatment in spinal muscular atrophy (SMA). This commitment to unlocking fundamentally different therapeutic approaches is powered by broad application of a proprietary platform, which has developed novel monoclonal antibodies to modulate protein growth factors with extraordinary selectivity. By harnessing cutting‑edge science in disease spaces that are historically under‑addressed through traditional therapies, Scholar Rock works every day to create new possibilities for patients.

Learn more at  and follow @Scholar Rock and on Linked In.

Reporting to the SVP of Medical Affairs, the Global Head, Scientific Communication will manage a team of publication Toby and medical communication leads to drive and oversee the oppression and execution of our medical, clinical, and scientific data dissemination strategy. The strategy includes tactics for external communications through publications including abstract submissions to medical and scientific congresses, posters, platform presentations, manuscripts (primary and secondary) and medical education tools (approved slide decks, medical booth resources, symposia and advisory board content).

Internal communication tactics include development of the scientific platform, lexicon, FAQs/backgrounders and annotations. Tactical implementation will involve collaboration with external authors and academic experts to motivate, drive and encourage collaborating co‑authors and internal resources towards successful publications and development of relevant medical education materials. In addition to authors, a key element of this role will require working closely with cross‑functional teams and internal stakeholders from multiple regions and countries to drive the integration of scientific, clinical, and commercial priorities.

The ideal candidate will have experience and a proven track record of success in the biotechnology or pharmaceutical industry, with a strong background in publication planning, medical communications and medical affairs activities. This is an exciting opportunity to be part of a passionate, high profile, high‑impact global medical affairs team, and work in a highly dynamic and collaborative setting. Domestic and international travel (20‑25 percent).

Although a physical presence in Cambridge is preferred, a remote employee who is able to travel to Cambridge regularly will also be considered.